Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish ...
U.S.-listed shares of Israel's Nano-X Imaging Ltd fell nearly 20% on Tuesday after short-seller Muddy Waters joined Citron Research in raising doubts over the company's diagnostic product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback